Millennium Management LLC bought $141k of FTH
owner at Sensei Biotherapeutics, Inc.. 4,215 shares at an average of $33.54, traded Apr 2, 2026, filed May 15, 2026.
Score components
- +12Role10% owner
- +11Trade size$141k at market
- 0Relative to holdingsHoldings up 2.9%
- 0Price contextNear the top of the 52-week range
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying3 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -36.4%, 3m +58.3%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-062608, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 2, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +26 | $33.47 | $870 | 144,974 | May 15, 2026 |
| Apr 2, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +1,276 | $34.75 | $44k | 144,974 | May 15, 2026 |
| Apr 2, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +701 | $35.55 | $25k | 144,974 | May 15, 2026 |
| Apr 2, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -3,099 | $30.86 | $96k | 144,974 | May 15, 2026 |
| Apr 2, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -1,265 | $31.75 | $40k | 144,974 | May 15, 2026 |
| Apr 2, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -1,794 | $32.60 | $58k | 144,974 | May 15, 2026 |
| Apr 2, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -374 | $33.35 | $12k | 144,974 | May 15, 2026 |
| Apr 2, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -1,134 | $34.80 | $39k | 144,974 | May 15, 2026 |
| Apr 6, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +1,104 | $31.02 | $34k | 141,029 | May 15, 2026 |
| Apr 6, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -1,214 | $31.02 | $38k | 141,029 | May 15, 2026 |
| Apr 6, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -45 | $31.96 | $1,438 | 141,029 | May 15, 2026 |
| Apr 7, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +1,108 | $33.38 | $37k | 133,986 | May 15, 2026 |
| Apr 7, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -2,115 | $28.94 | $61k | 133,986 | May 15, 2026 |
| Apr 7, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -205 | $29.71 | $6,091 | 133,986 | May 15, 2026 |
| Apr 7, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -4,423 | $31.38 | $139k | 133,986 | May 15, 2026 |
| Apr 7, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -300 | $32.25 | $9,674 | 133,986 | May 15, 2026 |
| Apr 7, 2026 | SOpen-market sale Common Stockindirect: See Footnote | -1,108 | $33.38 | $37k | 133,986 | May 15, 2026 |
Related signals
Other insiders at Sensei Biotherapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 64Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $326k 13,634 shares | +41% | |
| 69Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $401k 15,641 shares | +90% | |
| 62Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $406k 17,413 shares | - | |
| 43Moderate | Sensei Biotherapeutics, Inc. | Anand Kiran Parikh President and CEO | $55k 2,806 shares | +0% | |
| 43Moderate | Sensei Biotherapeutics, Inc. | Cambrian BioPharma Inc owner | $501k 25,000 shares | -16% | |
| 43Moderate | Sensei Biotherapeutics, Inc. | James Peyer owner, other | $501k 25,000 shares | -16% | |
| 39Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $818k 30,585 shares | +23% | |
| 21Weak | FTHsell Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $89k 3,250 shares | -2% | |
| 31Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $382k 12,180 shares | +8% | |
| 20Weak | FTHsell Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $77k 2,741 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.